Changes

161 bytes added ,  12:36, 20 August 2023
no edit summary
Line 4: Line 4:  
*Please complete the [https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>] and the Editor-in-Chief will be happy to discuss your interests and next steps.
 
*Please complete the [https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>] and the Editor-in-Chief will be happy to discuss your interests and next steps.
   −
#Pages in need of authors can be found here: <u>[[Volunteer Assignments and Opportunities]]</u> (''see “Authors” column and look for any that are not assigned''; every attempt is made to keep this updated). 
+
#Pages in need of authors can be found here: <u>[[Volunteer Assignments and Opportunities]]</u> (''see “Authors” column and look for any that are not assigned''; every attempt is made to keep this updated).
 +
#Trainees are highly encouraged and welcome to participate in this effort.  Trainees are asked to work with a mentor to help review their page content before completion.  If the trainee needs help identifying a mentor, one can be provided upon request.
 
#We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books. Therefore, if there is an entity not yet listed that you would like to author, we would be happy to create a page for you now.
 
#We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books. Therefore, if there is an entity not yet listed that you would like to author, we would be happy to create a page for you now.
 
#For diseases that are present in multiple WHO books, our goal is to have a main page for a disease entity from one book (the primary book is selected based on being the most relevant), and then the pages for the same entity in other books would refer to that page plus have their book-specific (''i.e.,'' body site) content. It is appreciated if the same author could volunteer for the related pages.
 
#For diseases that are present in multiple WHO books, our goal is to have a main page for a disease entity from one book (the primary book is selected based on being the most relevant), and then the pages for the same entity in other books would refer to that page plus have their book-specific (''i.e.,'' body site) content. It is appreciated if the same author could volunteer for the related pages.
Line 28: Line 29:  
**Use [https://www.genenames.org/ HUGO-approved gene names and symbols] (italicized when appropriate), [https://varnomen.hgvs.org/ HGVS-based nomenclature for variants], as well as generic names of drugs and testing platforms or assays if applicable
 
**Use [https://www.genenames.org/ HUGO-approved gene names and symbols] (italicized when appropriate), [https://varnomen.hgvs.org/ HGVS-based nomenclature for variants], as well as generic names of drugs and testing platforms or assays if applicable
 
**The use of bullet points alongside short blocks of text rather than only large paragraphs is encouraged.
 
**The use of bullet points alongside short blocks of text rather than only large paragraphs is encouraged.
 +
**Additional section-based instructions can be found in the Word templates.
    
<br />
 
<br />
Line 36: Line 38:  
#Delete the statement "This page is under construction. We need you help! Please consider joining in the project and submitting a review".
 
#Delete the statement "This page is under construction. We need you help! Please consider joining in the project and submitting a review".
 
#Email the appropriate Associate Editor that the page is complete.
 
#Email the appropriate Associate Editor that the page is complete.
  −
*Trainees are highly encouraged and welcome to participate in this effort.  Trainees are asked to work with a mentor to help review their page content before completion.
      
<br />
 
<br />
   −
*For technical issues or any additional questions, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]'''.  If applicable, please include the title of the page on which the error occurred, a screenshot of the error message, the web browser you were using (i.e. firefox, google chrome, internet explorer, etc) and any other pertinent information.
+
*For technical issues or any additional questions, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]'''.  If applicable, please include the title of the page on which the error occurred, a screenshot of the error message, the web browser you were using (''i.e.,'' firefox, google chrome, internet explorer, etc) and any other pertinent information.
    
<br />
 
<br />